about
Applying nanomedicine in maladaptive inflammation and angiogenesis.Target-or-Clear Zirconium-89 Labeled Silica Nanoparticles for Enhanced Cancer-Directed Uptake in Melanoma: A Comparison of Radiolabeling Strategies.Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles.Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.Nanoscale artificial antigen presenting cells for cancer immunotherapy.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Cancer nanomedicines: oversold or underappreciated?
@ast
Cancer nanomedicines: oversold or underappreciated?
@en
type
label
Cancer nanomedicines: oversold or underappreciated?
@ast
Cancer nanomedicines: oversold or underappreciated?
@en
prefLabel
Cancer nanomedicines: oversold or underappreciated?
@ast
Cancer nanomedicines: oversold or underappreciated?
@en
P2860
P1476
Cancer nanomedicines: oversold or underappreciated?
@en
P2093
Wim E Hennink
P2860
P356
10.1080/17425247.2017.1262346
P407
P577
2016-11-17T00:00:00Z